The BMJ might be right, but also have constructed an article that will be wildly misunderstood... and not sensible content for facebook.
Also, as the article points out, investigations were performed at other contractors. Wild speculation, but that could be that Pfizer didn't even need a full 44k and they just ignored 1k? (For example, they concluded the trial with 41k getting a second dose.)
Without this vigilance how do you distinguish between ivermectin studies that showed a positive effect and vaccine studies? Some of ivermectin studies but not all were discovered to be total frauds. At some point when you see too many problems you just have to distrust them by default until proved otherwise.
In fact, I think that there is possibility that the Pfizer vaccine trial results turned out quite different from effectiveness in real life in part due to issues like this.
> An FDA review memorandum released in August this year states that across the full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19.
Of course, this comes after insinuating earlier that there is a complete lack of oversight.
> “There’s just a complete lack of oversight of contract research organisations and independent clinical research facilities,” says Jill Fisher, professor of social medicine at the University of North Carolina School of Medicine and author of Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials.
I guess since you yourself were misled according to their own inconsistencies, maybe that is enough to convince you that the article is misleading.
Sorry, I don't see any inconsistencies. The box clearly explains what they mean by complete lack of oversight – doing inspections many months after the trial and even then just checking the paperwork.
Blocking the article (instead of opening relevant books to show that in fact it was just exception to otherwise solid prices makes) makes even stronger case that the prices is not honest.
The first question in everybody's head when reading this article is, "Were the vaccine trials legitimate or not?"
BMJ does not even come close to truthfully answering this question. With their authority as a medical journal and a very limited amount of evidence, they give a clear and incorrect impression that the vaccine trials were not legitimate.
Do they report on the limitations of their evidence? No. Do they report on the perspective of employees at other trial sites? No. Do they get quotes from Pfizer, other health orgs, Ventavia executives? No. Do they report about other speculative factors at play from Ventavia ex-employees? No.
Are they purposefully hiding new relevant information? Yes. They leaked in their own article that the FDA is aware and reviewed the Ventavia trial.
> An FDA review memorandum released in August this year states that across the full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19.
After insinuating earlier that there is a complete lack of oversight.
> “There’s just a complete lack of oversight of contract research organisations and independent clinical research facilities,” says Jill Fisher, professor of social medicine at the University of North Carolina School of Medicine and author of Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials.
Honestly, BMJ seems to be working very hard to lie using true facts. I have no objections to their articles being marked as false.
You are writing complete rubbish. BMJ does not question the legitimacy of the vaccine trials. With this sentence you are making very serious accusations to healthcare professionals. Most likely you don't even understand how clinical trials work or terminology used in the original article. If BMJ were not a serious journal, nothing in medicine would be serious including those trials.
BMJ is questioning some irregularities brought to the light by a whistle-blower. It shows some evidence confirming issues about one particular clinical research organization and lack of reaction from the FDA. These issues should be addressed and resolved to remove doubts that the data from vaccine trials can be sufficiently trusted.
Also FDA memorandum does not confirm that the FDA has investigated the sites. You probably don't even understand what the quoted professor meant by “oversight”. It definitely is not just checking and fully trusting the submitted paperwork.
The singular "trial" in the headline implies that the flaws are in the trial as a whole rather than in a particular distinct subset of the trials.
Pfizer had one large trial that involved many sites. Three of those sites run by Ventavia had problems. That's why the headline says “in trial”. But even if you didn't know that it is explained in BMJ article “... Ventavia had enrolled more than 1000 participants at three sites. The full trial (registered under NCT04368728) enrolled around 44 000 participants across 153 sites that included numerous commercial companies and academic centres.”
The argument that just because one of a company's trials are unsound doesn't mean that the rest aren't is not a good one, when the whole objective is to provide assurance in proving the safety of a product.
I can see room for misunderstanding no matter what. Emphasize the portion of sites where the problem was observed and it wrongly can be inferred that the other sites are fine even if they have no evidence either way. Emphasize the problem as a generic feature of the trials overall and it can be wrongly inferred that the whistle is being blown on some aspect of the trial that doesn't have any site-specific aspect.
The story that I'm hearing in all this is that the whistleblower brought out issues that were specific to certain sites in a way that has no direct bearing on other sites besides being a reason to scrutinize the rest of the sites as well.
Maybe an analogy would be helpful. If a whistleblower observed a disregard for safety protocols at a food processing facility, that's not a randomized sampling that indicates a high likelihood of the problem being throughout all similar facilities, but it doesn't indicate otherwise either. It opens the question whether this is a typical problem in such facilities or if that facility is an exception. If the facility was supplying brand X, there's at least some sense to criticizing a headline like "whisteblower reveals brand X unsafe food handling" instead of "whistleblower reveals unsafe food handling at facility run by brand X". The former implies wider issues, the latter errs toward not making that presumption.
We all know that the trials were rushed and for a very good reason, there was a pandemic. Still, if issues are discovered they should be resolved. Pfizer is a private company, they are not obliged to be very transparent with everything they do. FDA is the main organisation that oversees such trial in the US, so this is their responsibility to investigate.
I disagree. One bad study doesn't mean all scientific conclusions are bad. One bad study doesn't mean Pfizer's trials are bad. Ignorance doesn't prove anything...
I wasn't saying that one bad study means the overall trial was bad.
The issue is that SOME people might think that. (Also others might think that if it's ONE study that's bad, the overall trial WAS fine, when that's not clear either).
The risk is whether real people take away a too-strong message and run with it.
In other words, journalists have SOME responsibility to not mislead people even when the main way people get off-track is their own erroneous jumping-to-conclusions as readers. We KNOW that readers do such things, so we have to be careful to minimize it.
If the FDA did not follow up on the whistleblower report it raises far broader questions about oversight of the trials as a whole.
I totally understand that when BMJ writes that this clinical research organization did a mess is this trial, someone misreads it as all Pfizer vaccine results are false. But if you say that BMJ is hoax, then we have much stronger reason to distrust healthcare professionals. Do you see the paradox here?
BMJ is expressing concern about Pfizer and regulator's failures with the ultimate aim to fix them and increase the trust by showing that every fault is taken seriously. We cannot sweep unwanted things under the carpet and hope that nothing will happen. Bad actors should be appropriately punished.
Probably the wrong way to think about things but that's how my mind works.
> Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight.
The questions are all whether this one company had poor practices. It mixes comments regarding the larger trial of Pfizer with this isolated company trial. At times it's hard to tell if they're referencing Pfizer or Ventavia (as "company"). An investigation found nothing remarkable at other sites managed by other contractors, but then even that is questioned because this small company wasn't investigated.
I'm not actually sure what part of this medical journal _is_ factual.